Insider · CIK 0002059127
Qiming Corporate GP VI, Ltd.
Files at ALMR (Alamar Biosciences, Inc.). First filing -, latest -.
In brief
Qiming Corporate GP VI, Ltd. files SEC Form 4 as 10% owner at ALMR (Alamar Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Qiming Corporate GP VI, Ltd. has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 20 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +185,163 | - | - | 185,163 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +6,881,410 | - | - | 6,881,410 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +1,605,645 | - | - | 1,605,645 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +1,922,329 | - | - | 1,922,329 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: See footnote | -185,163 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: See footnote | -6,881,410 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: See footnote | -1,605,645 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: See footnote | -1,922,329 | - | - | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: See footnote | +185,163 | - | - | 185,163 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: See footnote | +6,881,410 | - | - | 6,881,410 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: See footnote | +1,605,645 | - | - | 1,605,645 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: See footnote | +1,922,329 | - | - | 1,922,329 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-3 Preferred Stockderivativeindirect: See footnote | -172,328 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-3 Preferred Stockderivativeindirect: See footnote | -6,404,332 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-4 Preferred Stockderivativeindirect: See footnote | -154,425 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-4 Preferred Stockderivativeindirect: See footnote | -5,738,971 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series B Preferred Stockderivativeindirect: See footnote | -113,625 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series B Preferred Stockderivativeindirect: See footnote | -4,222,738 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series C Preferred Stockderivativeindirect: See footnote | -3,882,451 | $0.00 | $0 | 0 | Apr 22, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series C Preferred Stockderivativeindirect: See footnote | -4,648,194 | $0.00 | $0 | 0 | Apr 22, 2026 |
Questions about Qiming Corporate GP VI, Ltd.
Answered from the filings on this page, as of the latest one.
Is Qiming Corporate GP VI, Ltd. buying or selling?
Qiming Corporate GP VI, Ltd. has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Qiming Corporate GP VI, Ltd.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Qiming Corporate GP VI, Ltd. has 0.
Where does Qiming Corporate GP VI, Ltd. file Form 4?
Qiming Corporate GP VI, Ltd. has filed Form 4 at ALMR (Alamar Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.